Xinan Qiao

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

Jun Ma, Xinan Qiao, Tristan Knight et al. · Clinical Cancer Research · 2019 · 172 citations · Full text

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

Xinan Qiao, Jun Ma, Tristan Knight et al. · Blood Cancer Journal · 2021 · 39 citations · Full text

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

Shuang Liu, Xinan Qiao, Shuangshuang Wu et al. · APOPTOSIS · 2022 · 24 citations

Hematological Malignancy, Mcl-1-selective Inhibitor Azd5991, Mixed-phenotype Acute Leukemia +9

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

Katie Hege-Hurrish, Xinan Qiao, Xinyu Li et al. · Biochemical Pharmacology · 2022 · 21 citations · Full text

Hematological Malignancy, Mitochondrial Function, Mixed-phenotype Acute Leukemia +8

Calf Spleen Extractive Injection protects mice against cyclophosphamide-induced hematopoietic injury through G-CSF-mediated JAK2/STAT3 signaling

Wenqian Lu, Dongxu Jia, Shengshu An et al. · Scientific Reports · 2017 · 19 citations · Full text